ACM-Pivotal Vice President Named to Advisory Board at Rochester Institute of Technology.

Elena Logan Tapped to Help Form Clinical Research Management Program for Center for Bioscience Education and Technology

ROCHESTER, N.Y. -- ACM-Pivotal, the global central laboratory that continually defines the customer-service standard with its inherently flexible approach, today announced Elena Logan's participation on the Bioscience Workforce Development Advisory Board at Rochester Institute of Technology's (RIT) Center for Bioscience Education and Technology. The Center has identified Clinical Research Management as an emerging arena that is demanding a highly-specialized and well-educated workforce.

As part of RIT's Master of Science in Professional Studies, Clinical Research Management will be a study program focused on graduate students interested in entering the clinical research industry. Logan's role on the Advisory Board gives her an opportunity to help shape the curriculum to ensure it will prepare graduates to immediately contribute and make an impact in several specialty functions within the clinical research community. The current direction of the curriculum covers essential clinical research and business skills in drug, device and biologic development from both the sponsor, site and support organizations perspectives.

Douglas Merrill is the director for the Center for Bioscience Education and Technology, and has been a member of the RIT faculty since 1980. "Elena was an obvious choice for the Advisory Board because of her vast experience with clinical trials and interest in our regional economy. Her real-world pulse on this industry will enable us to make the program totally relevant to potential employers around the country. Of course, we cannot hope to be successful without the direct input of people like Elena, and we are so grateful for her participation," said Merrill.

Logan has spent 19 years in the clinical research industry. Her experience is comprised of project management for a major pharmaceutical company, and clinical operations and business development in the clinical research organization (CRO) industry. Currently she is VP, Clinical Trials for ACM-Pivotal, a global central lab based in Rochester. In her present role, Logan is responsible for overall growth and business strategy.

"I am excited to be part of something so critical for the clinical research industry," said Logan. "There is a significant need for a curriculum focused on drug development that provides a real world perspective. This will better prepare professionals for a career in clinical trials thus, expediting the drug development process. I am happy to dedicate my time and effort to making this a renowned program that is sought-after by graduates around the country."

The Clinical Research Management program will feature courses on such topics as Drug and Device Industry Overview, Good Clinical Practice, Ethics in Science and Clinical Research, as well as business-focused courses on Project Management, Business/Cost Management and Communication and Leadership. Potential specialized curriculum includes Clinical Trial Design and Conduct, Statistical Analysis, and Regulatory Compliance. The target date for a part-time program is September 2007, with the first full-time class enrolled by September 2008.

About RIT's Center for Bioscience Education and Technology

The Center for Bioscience Education and Technology (CBET) is the Rochester region's hub for customized workforce training and professional-development services in the biosciences. As a complement to RIT's traditional academic degree programs, CBET serves a broad and diverse population of bioscience workers and others whose professions intersect regularly with the bioscience and health-related fields.

About ACM-Pivotal

ACM-Pivotal is the global central laboratory with an inherently flexible approach and a focus on precision to keep clinical research studies on schedule. The organization sets itself apart by its single focus on global central lab services. ACM-Pivotal is defining the industry standard by continually developing client-focused processes and services. ACM-Pivotal's global operations extend to more than 60 countries and offer a broad and customized menu of safety and specialty services for clinical trials. The organization performs 10 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including Pathology, Microbiology and Pharmacogenomics. For more information, visit www.acm-pivotal.com.